Literature DB >> 1367287

Rapid PCR-cloning of full-length mouse immunoglobulin variable regions.

S T Jones, M M Bendig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1367287     DOI： 10.1038/nbt0691-579

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN： 0733-222X


× No keyword cloud information.
  5 in total

1.  Development of a human-murine chimeric immunoglobulin M antibody for use in the serological detection of human flavivirus antibodies.

Authors:  Brett A Thibodeaux; John T Roehrig
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

2.  Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.

Authors:  Bailin Tu; Robert N Ziemann; Bryan C Tieman; David J Hawksworth; Joan Tyner; James Scheffel; Mary S Pinkus; Susan E Brophy; Jeffrey M Werneke; Robin Gutierrez; Michael White
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

3.  Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.

Authors:  C Panousis; V M Rayzman; T G Johns; C Renner; Z Liu; G Cartwright; F-T Lee; D Wang; H Gan; D Cao; A Kypridis; F E Smyth; M W Brechbiel; A W Burgess; L J Old; A M Scott
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

4.  Multimerization is required for antigen binding activity of an engineered IgM/IgG chimeric antibody recognizing a skin-related antigen.

Authors:  Kwesi Teye; Koji Hashimoto; Sanae Numata; Kunihiro Ohta; Marek Haftek; Takashi Hashimoto
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.

Authors:  Michelle L Scalley-Kim; Bruce W Hess; Ryan L Kelly; Anne-Rachel F Krostag; Kurt H Lustig; John S Marken; Pamela J Ovendale; Aaron R Posey; Pamela J Smolak; Janelle D L Taylor; C L Wood; David L Bienvenue; Peter Probst; Ruth A Salmon; Daniel S Allison; Teresa M Foy; Carol J Raport
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.